External site links:
The Bristol, North Somerset, & South Gloucestershire (BNSSG) Joint Formulary
NOTE: THIS FORMULARY DOES NOT APPLY TO PAEDIATRICS. There is a separate paediatric section on the left hand side sub-menu which contains Formulary decisions and NICE technology appraisals relating to paediatrics.
Please see the 'Recent Joint Formulary Group Decisions' for the most recent changes to the website
During 2015 all the chapters of the formulary have been reviewed and updated. During Dec 2015 and Jan 2016 the old chapters will be replaced with the updated chapters
Look in the Newsletter section for up to date information regarding the formulary - June 2016
The Joint Formulary has been built in the spirit of cooperative collaboration between Bristol, North Somerset and South Gloucestershire and has been designed as an advisory/guidance tool to assist in promoting cost-effective prescribing within the BNSSG Health Community. It is a joint venture between primary and secondary care, covering all prescribing within the BNSSG Health community. This therefore ensures that patients have continuity of medicines across the primary/secondary care interface.
It is hoped that the Joint Formulary will cover 80-90% of prescribing although it is recognised that there will be instances where prescribing outside of the formulary will be necessary. Where medicines are not listed and therefore non-formulary either complete an IFR application and submit to the relevant IFR panel for individual patient requests where exceptionality can be shown or complete a new drug application form to be considered for Formulary approval.
The Joint Formulary is a constantly evolving and dynamic document. Please use the contact link provided to get in touch.